These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 6168226)

  • 1. Determinants of the anticoagulant effect of heparin in vitro.
    Bjornsson TD; Wolfram KM
    Ann N Y Acad Sci; 1981; 370():656-61. PubMed ID: 6168226
    [No Abstract]   [Full Text] [Related]  

  • 2. Intersubject variability in the anticoagulant response to heparin in vitro.
    Bjornsson TD; Wolfram KM
    Eur J Clin Pharmacol; 1982; 21(6):491-7. PubMed ID: 6176454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between the antithrombotic and anticoagulant effects of low molecular weight heparin.
    Carter CJ; Kelton JG; Hirsh J; Gent M
    Thromb Res; 1981 Jan 1-15; 21(1-2):169-74. PubMed ID: 7233399
    [No Abstract]   [Full Text] [Related]  

  • 4. The antiheparin effect of alpha 1-acid glycoprotein: influence on heparin tolerance during the acute phase reaction.
    Andersen P; Kierulf P; Godal HC
    Thromb Res; 1981 Jun 1-25; 22(5-6):593-602. PubMed ID: 6171047
    [No Abstract]   [Full Text] [Related]  

  • 5. Characterization of a new potent heparin. 1 communication: Determinations of anticoagulant activity of a high potency heparin preparation in vivo using dog as an experimental animal and in vitro using dog and human plasma.
    Bhargava AS; Heinick J; Schöbel C; Günzel P
    Arzneimittelforschung; 1980; 30(6):993-6. PubMed ID: 7191280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of rivaroxaban, in contrast to heparin, is similar in neonatal and adult plasma.
    Novak M; Schlagenhauf A; Bernhard H; Schweintzger S; Leschnik B; Muntean W
    Blood Coagul Fibrinolysis; 2011 Oct; 22(7):588-92. PubMed ID: 21799400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postheparin plasma diamine oxidase activity and the anticoagulant effect of heparin.
    Klocker J; Drasche A; Sattler J; Bodner E; Schwelberger HG
    Inflamm Res; 2000 Apr; 49 Suppl 1():S53-4. PubMed ID: 10864420
    [No Abstract]   [Full Text] [Related]  

  • 8. Anticoagulant property of a semi-synthesized sodium beta-1,4-glucan sulfate.
    Wang ZM; Li L; Li B; Guo SY
    Yao Xue Xue Bao; 2006 Apr; 41(4):323-7. PubMed ID: 16856476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of a new potent heparin. 7th communication: A comparative study of a new potent heparin in human after i.v. application.
    Bhargava AS; Wendt H; Günzel P
    Arzneimittelforschung; 1981; 31(2):386-8. PubMed ID: 7194658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the blood coagulation profiles of ferrets and rats.
    Takahashi S; Hirai N; Shirai M; Ito K; Asai F
    J Vet Med Sci; 2011 Jul; 73(7):953-6. PubMed ID: 21427521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparin affin regulatory peptide modulates the endogenous anticoagulant activity of heparin and heparan sulphate mimetics.
    Mejdoubi-Charef N; Courty J; Sineriz F; Papy-Garcia D; Charef S
    Basic Clin Pharmacol Toxicol; 2012 Nov; 111(5):296-302. PubMed ID: 22672269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The anticoagulant effect of antithrombin/heparin complex. A new screening test to detect a thrombophilic tendency?
    Makris PE; van Dreden P
    Blood Coagul Fibrinolysis; 1998 Oct; 9(7):665-6. PubMed ID: 9863719
    [No Abstract]   [Full Text] [Related]  

  • 13. Anticoagulant effect of unfractionated heparin in antithrombin-depleted plasma in vitro.
    Krulder JW; Strebus AF; Meinders AE; Briët E
    Haemostasis; 1996; 26(2):85-9. PubMed ID: 9119287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heparin is an unsuitable anticoagulant for the detection of plasma ammonia.
    Wannasilp N; Sribhen K; Pussara N; Hwanpuch T; Wangchaijaroenkit S; Opartkiattikul N
    Clin Chim Acta; 2006 Sep; 371(1-2):196-7. PubMed ID: 16678809
    [No Abstract]   [Full Text] [Related]  

  • 15. [Mechanisms of heparin resistance and their clinical significance].
    Barkagan ZS; Lychev VG; Bishevskiĭ KM; Tsyvkina LP; Glazunova GA
    Ter Arkh; 1982; 54(8):77-82. PubMed ID: 6753220
    [No Abstract]   [Full Text] [Related]  

  • 16. Heparin from bovine intestinal mucosa: glycans with multiple sulfation patterns and anticoagulant effects.
    Tovar AM; Capillé NV; Santos GR; Vairo BC; Oliveira SN; Fonseca RJ; Mourão PA
    Thromb Haemost; 2012 May; 107(5):903-15. PubMed ID: 22437650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Chitosan Derivative N-[(2-Hydroxy-3-Trimethylammonium)Propyl]Chloride on Anticoagulant Activity of Guinea Pig Plasma.
    Drozd NN; Shagdarova BT; Il'ina AV; Varlamov VP
    Bull Exp Biol Med; 2017 Jul; 163(3):340-343. PubMed ID: 28744652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Unexpectedly prolonged thrombin time].
    Barth A; Furlan M; Lämmle B
    Schweiz Med Wochenschr; 1993 Mar; 123(12):523-9. PubMed ID: 8475358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antithrombin activity and prolongation of thrombin time; comparative study of heparin and of some synthetic heparinoids].
    BURSTEIN M; GUINAND A
    Arch Int Pharmacodyn Ther; 1955 Jun; 102(1-2):96-104. PubMed ID: 13239250
    [No Abstract]   [Full Text] [Related]  

  • 20. Anticoagulant effects of inhaled unfractionated heparin in the dog as determined by partial thromboplastin time and factor Xa activity.
    Manion JS; Thomason JM; Langston VC; Claude AK; Brooks MB; Mackin AJ; Lunsford KV
    J Vet Emerg Crit Care (San Antonio); 2016; 26(1):132-6. PubMed ID: 26194053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.